| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/03/2008 | US7381800 Antibodies to HBIMF63 polypeptide |
| 06/03/2008 | US7381797 Stabilization of H2O2 under alkaline conditions for use in luminescence, fluorescence and colorimetric assays for enhanced detection of peroxidase type assays |
| 06/03/2008 | US7381708 Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye |
| 06/03/2008 | US7381571 Multilayer thermoconductive metal substrate with a corrosion resistant plastic coating defining a sample-distribution network having an inlet, detection chambers loaded with detection reagents, and a channel providing a dead-end fluid connection between each chamber and the inlet |
| 06/03/2008 | US7381570 Multilayer thermoconductive metal substrate defining a sample-distribution network having an inlet, detection chambers loaded with reagents, and a channel providing a dead-end fluid connection between each chamber and the inlet; optional temperature-controller |
| 06/03/2008 | US7381569 Device and method for multiple analyte detection |
| 06/03/2008 | US7381567 Labeling reactant with lanthanide ion or chelate, separating reaction product; solution containing beta -diketone alkyl chain with fluorines; europium, terbium, samarium, dysprosium |
| 06/03/2008 | US7381554 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/N-acetylglucosamine-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 06/03/2008 | US7381549 Method for zymotic production of fine chemicals (mety) containing sulphur |
| 06/03/2008 | US7381547 Methods and compositions to detect bacteria using multiplex PCR |
| 06/03/2008 | US7381546 Immunosuppressant selected from prolyl-rapamycin, 4-hydroxy-prolyl-rapamycin, 4-hydroxyprolyl-26-demethoxy-rapamycin, 3-hydroxy-prolyl-rapamycin, 3-hydroxy-prolyl-26-demethoxy-rapamycin, and trans-3-aza-bicyclo[3,1,0]hexane-2-carboxylic acid rapamycin |
| 06/03/2008 | US7381540 Composition for measuring glucose having improved substrate specificity |
| 06/03/2008 | US7381539 Method of assay by oxidation-reduction reaction with formazan |
| 06/03/2008 | US7381538 Optical biosensor with enhanced activity retention for detection of halogenated organic compounds |
| 06/03/2008 | US7381537 Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease |
| 06/03/2008 | US7381536 Analysis of platelet reactivity and/or velocity of thrombin or fibrin formation; thromboelastography maximum amplitude |
| 06/03/2008 | US7381535 Methods and compositions for detecting receptor-ligand interactions in single cells |
| 06/03/2008 | US7381533 Electrodes linked via oligomers to nucleic acids |
| 06/03/2008 | US7381532 Incubating with polymerase component; FEN nuclease splitting; detecting and/or measuring fragment released |
| 06/03/2008 | US7381531 Apparatus which utilizes a complex of an anti-cocaine aptamer and diethylthiotricarbocyanine dyes to detect cocaine in solution; drug testing; calorimetric sensor |
| 06/03/2008 | US7381530 Using site specific cleavage as tool in cancer diagnosis, paternity testing, forensic analysis and detecting viral/bacterial infection |
| 06/03/2008 | US7381529 Methods and compositions for detecting nucleic acids using scanning probe microscopy and nanocodes |
| 06/03/2008 | US7381528 Methods for detection of mutations in myostatin variants |
| 06/03/2008 | US7381527 Method of detection of SP-A2 gene variants |
| 06/03/2008 | US7381526 Assays for drug discovery based on microcompetition with a foreign polynucleotide |
| 06/03/2008 | US7381525 Coupled to electrodes via conductive oligomers; site-selective modification using electron transfer moieties |
| 06/03/2008 | US7381524 Using immunoglobulin specific to turkey astrovirus capsid protein as tool for detecting single-stranded RNA viral infection in avians; immunodiagnostics |
| 06/03/2008 | US7381523 Methods for identifying compounds for treating diabetes mellitus |
| 06/03/2008 | US7381522 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381401 T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase |
| 06/03/2008 | US7381373 System and method for preparative mass spectrometry |
| 06/03/2008 | CA2296072C Oligonucleotide primers for efficient reverse transcription of hepatitis c virus (hcv) rna and methods of use thereof |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2220563C Protein production in transgenic alfalfa plants |
| 06/03/2008 | CA2195528C Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 06/03/2008 | CA2160016C Method of forming oligonucleotides |
| 05/29/2008 | WO2008064304A2 Compositions and methods for the identification of inhibitors of protein synthesis |
| 05/29/2008 | WO2008064299A2 Methods of reducing porcine circovirus-associated disease outbreaks |
| 05/29/2008 | WO2008064239A2 Imidazolidine derivative mass tags |
| 05/29/2008 | WO2008064184A2 Method of detecting large genomic rearrangements |
| 05/29/2008 | WO2008064138A2 Personalized therapeutic treatment process |
| 05/29/2008 | WO2008064016A2 Detecting molecular interactions |
| 05/29/2008 | WO2008063838A2 Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms |
| 05/29/2008 | WO2008063783A2 Biomarkers related to metabolic age and methods using the same |
| 05/29/2008 | WO2008063769A2 Prostate cancer-specific alterations in erg gene expression and detection and treatment methods based on those alterations |
| 05/29/2008 | WO2008063758A2 Multifunctional encoded particles for high-throughput analysis |
| 05/29/2008 | WO2008063655A2 Dna methylation markers and methods of use |
| 05/29/2008 | WO2008063521A2 Gene-based clinical scoring system |
| 05/29/2008 | WO2008063414A2 Gene expression profiling for identification, monitoring, and treatment of colorectal cancer |
| 05/29/2008 | WO2008063413A2 Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| 05/29/2008 | WO2008063194A1 Dual function primers for amplifying dna and methods of use |
| 05/29/2008 | WO2008063145A1 Device for examining animal and vegetable products |
| 05/29/2008 | WO2008062907A1 Substance capable of inhibiting cytokinin signaling |
| 05/29/2008 | WO2008062855A1 A method of detecting defects in dna microarray data |
| 05/29/2008 | WO2008062385A2 Antiretroviral drug resistance testing |
| 05/29/2008 | WO2008062359A2 Method of use of epiregulin protein and nucleic acid encoding the same in inflammatory conditions |
| 05/29/2008 | WO2008062309A2 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus |
| 05/29/2008 | WO2008062136A2 Method for diagnosis of and following a bacterial vaginosis by molecular quantification |
| 05/29/2008 | WO2008062105A1 Method for predicting the response to a therapy |
| 05/29/2008 | WO2008061804A2 Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
| 05/29/2008 | WO2008061801A1 Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
| 05/29/2008 | WO2008061673A2 Drug discovery for cancer |
| 05/29/2008 | WO2008061672A2 Genetic risk factor for cancer |
| 05/29/2008 | WO2008061626A1 Method for detecting pyrophosphate by means of bioluminescence detection |
| 05/29/2008 | WO2008061537A2 Oligonucleotides for modulating target rna activity |
| 05/29/2008 | WO2008061527A2 Prognostic markers for classifying colorectal carcinoma on the basis of expression profiles of biological samples |
| 05/29/2008 | WO2008061526A2 Prognostic marker for predicting the five-year progression-free survival of patients with colorectal carcinoma based on expression profiles of biological samples |
| 05/29/2008 | WO2008061525A2 Prognostic marker for classifying the three-year progression-free survival of patients with colorectal carcinoma based on expression profiles of biological samples |
| 05/29/2008 | WO2008061376A1 Methods and kits for detecting methicillin-resistant staphylococcus aureus |
| 05/29/2008 | WO2008061370A1 Diagnostic method to detect endometriosis |
| 05/29/2008 | WO2008040355A3 Novel methods for quantification of micrornas and small interfering rnas |
| 05/29/2008 | WO2008033164B1 Magnetic particle tagged reagents and techniques |
| 05/29/2008 | WO2008026102A3 Detection of hydrogen peroxide released by enzyme-catalyzed oxidation of an analyte |
| 05/29/2008 | WO2008024319A8 Microfluidic devices for nucleic acid assembly |
| 05/29/2008 | WO2008023179A3 Method for retaining even coverage of short insert libraries |
| 05/29/2008 | WO2008013893A3 Diagnosis and treatment of age related macular degeneration |
| 05/29/2008 | WO2008012576A3 Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment |
| 05/29/2008 | WO2008008808A3 Methods of introducing targeted diversity into nucleic acid molecules |
| 05/29/2008 | WO2008002165A3 A method, assay and kit for prediction and treatment of a human subject infected with a virus |
| 05/29/2008 | WO2007140279A3 Probes and kits for determining the presence of mycobacterium tuberculosis complex organisms in a test sample and method of amplifying gram-positive bacteria and fungi employing capture probe |
| 05/29/2008 | WO2007121272A8 Methods and compositions involving nucleotide repeat disorders |
| 05/29/2008 | WO2007121017A3 Mutations and polymorphisms of fms-like tyrosine kinase 4 |
| 05/29/2008 | WO2007109515A3 Mutations and polymorphisms of knockdown resistance polypeptide |
| 05/29/2008 | WO2007087291A3 Asymmetrical adapters and methods of use thereof |
| 05/29/2008 | WO2007075371A3 Protein modulators of resistance to alkylating agents |
| 05/29/2008 | WO2007070482A3 Microarray-based preimplantation genetic diagnosis of chromosomal abnormalities |
| 05/29/2008 | WO2007034210A8 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 05/29/2008 | WO2006137597A9 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 05/29/2008 | US20080127368 Enhancing insect resistance in plants via modifying scent protein expression; biological pest control; disease resistant plants |
| 05/29/2008 | US20080127367 Transgenic canola with improved meal quality |
| 05/29/2008 | US20080127365 Using vector transformation of leucine zipper homeodomain polypeptide gene sequences as tool in generating plants with enhanced crop yields |
| 05/29/2008 | US20080127361 Propagating disease resistant soybean; biological pest control through successive, generation breeding of plants comprising resistance to phytophthora sojae (RPS8) gene |
| 05/29/2008 | US20080127358 Expression vector comprising nucleotide sequences coding cell surface signaling peptides for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/29/2008 | US20080126052 Toxicity detector for liquid consumable by humans |
| 05/29/2008 | US20080125751 Temperature compensation for enzyme electrodes |
| 05/29/2008 | US20080125586 probes, modulators or detectors of the activity of cytochrome P450 monooxygenase enzyme system, used for high throughput drug screenning |
| 05/29/2008 | US20080125576 Protein isolation |
| 05/29/2008 | US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders |